Literature DB >> 8828618

A prefrontal dysfunction model of early-treated phenylketonuria.

M C Welsh1.   

Abstract

A prefrontal dysfunction model of early-treated phenylketonuria (PKU) is discussed. The biochemical perturbations caused by this genetic disorder have been found to result in depleted dopamine, a neurochemical that is critical for prefrontal cortical function. Studies of the neuropsychological sequelae of early-treated PKU in children are reviewed, and it is suggested that findings indicating executive function (EF) impairments are consistent with the prefrontal dysfunction hypothesis. An alternative model of the neuropsychological effects, that of a lefthemisphere dysfunction, is also discussed. Although a substantial amount of research has explored the neuropsychological performance of children with early-treated PKU, the extent to which these EF deficits are maintained into adolescence and adulthood is unclear. The neuropsychological expression of early-treated PKU across development requires further investigation and should provide a window on the general nature of brain development and function.

Entities:  

Mesh:

Year:  1996        PMID: 8828618     DOI: 10.1007/pl00014259

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Lateralized deficits in visual attention in males with developmental dopamine depletion.

Authors:  S Craft; M L Gourovitch; S B Dowton; J M Swanson; S Bonforte
Journal:  Neuropsychologia       Date:  1992-04       Impact factor: 3.139

2.  Monkey retardate learning analysis.

Authors:  A S Chamove; T J Molinaro
Journal:  J Ment Defic Res       Date:  1978-03

3.  Neuropsychological studies of the frontal lobes.

Authors:  D T Stuss; D F Benson
Journal:  Psychol Bull       Date:  1984-01       Impact factor: 17.737

4.  Neuropsychology of early-treated phenylketonuria: specific executive function deficits.

Authors:  M C Welsh; B F Pennington; S Ozonoff; B Rouse; E R McCabe
Journal:  Child Dev       Date:  1990-12

5.  Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons.

Authors:  L A Chiodo; M J Bannon; A A Grace; R H Roth; B S Bunney
Journal:  Neuroscience       Date:  1984-05       Impact factor: 3.590

6.  Psychiatric diagnosis and behavioral characteristics of phenylketonuric children.

Authors:  G M Realmuto; B D Garfinkel; M Tuchman; M Y Tsai; P N Chang; R O Fisch; S Shapiro
Journal:  J Nerv Ment Dis       Date:  1986-09       Impact factor: 2.254

7.  Early-treated phenylketonuria: neuropsychologic consequences.

Authors:  R L Brunner; M K Jordan; H K Berry
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

8.  Neuropsychological deficits in early treated phenylketonuric children.

Authors:  B F Pennington; W J van Doorninck; L L McCabe; E R McCabe
Journal:  Am J Ment Defic       Date:  1985-03

9.  Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.

Authors:  W Krause; M Halminski; L McDonald; P Dembure; R Salvo; D Freides; L Elsas
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

10.  Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function.

Authors:  F Güttler; H Lou
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

View more
  8 in total

1.  Tackling frontal lobe-related functions in PKU through functional brain imaging: a Stroop task in adult patients.

Authors:  Benedikt Sundermann; Bettina Pfleiderer; Harald E Möller; Wolfram Schwindt; Josef Weglage; Jöran Lepsien; Reinhold Feldmann
Journal:  J Inherit Metab Dis       Date:  2011-04-14       Impact factor: 4.982

2.  Executive function in treated phenylketonuria as measured by the one-back and two-back versions of the continuous performance test.

Authors:  P Griffiths; R Campbell; P Robinson
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

3.  Wechsler subscale IQ and subtest profile in early treated phenylketonuria.

Authors:  P V Griffiths; C Demellweek; N Fay; P H Robinson; D C Davidson
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

4.  Effects of dietary management of phenylketonuria on long-term cognitive outcome.

Authors:  Shelley Channon; Galya Goodman; Sally Zlotowitz; Caroline Mockler; Philip J Lee
Journal:  Arch Dis Child       Date:  2006-10-26       Impact factor: 3.791

5.  Neuropsychological outcome of experimental manipulation of phenylalanine intake in treated phenylketonuria.

Authors:  P Griffiths; N Ward; A Harvie; F Cockburn
Journal:  J Inherit Metab Dis       Date:  1998-02       Impact factor: 4.982

6.  A preliminary report on dopamine system reactivity in PKU: acute effects of haloperidol on neuropsychological, physiological, and neuroendocrine functions.

Authors:  Monica Luciana; Karen L Hanson; Chester B Whitley
Journal:  Psychopharmacology (Berl)       Date:  2004-03-13       Impact factor: 4.530

7.  High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial.

Authors:  Amber E ten Hoedt; Leo M J de Sonneville; Baudouin Francois; Nienke M ter Horst; Mirian C H Janssen; M Estela Rubio-Gozalbo; Frits A Wijburg; Carla E M Hollak; Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2010-12-10       Impact factor: 4.982

8.  The effects of tetrahydrobiopterin (BH4) treatment on brain function in individuals with phenylketonuria.

Authors:  Shawn E Christ; Amanda J Moffitt; Dawn Peck; Desirée A White
Journal:  Neuroimage Clin       Date:  2013-08-30       Impact factor: 4.881

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.